Eton Pharmaceuticals (ETON) Goodwill & Intangibles (2019 - 2026)
Eton Pharmaceuticals (ETON) posted Goodwill & Intangibles of $30.9 million for Q4 2025, down 3.14% sequentially from $31.9 million in Q3 2025, and down 11.48% YoY from $34.9 million in Q4 2024.
Eton Pharmaceuticals (ETON) Goodwill & Intangibles (2019 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Goodwill & Intangibles for 7 years, with the latest figure at $30.9 million in Q4 2025.
- Quarterly Goodwill & Intangibles fell 11.48% year-over-year to $30.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $30.9 million (down 11.48% YoY) and the FY2025 annual result came in at $30.9 million, down 11.48% from the prior year.
- Goodwill & Intangibles retreated to $30.9 million in Q4 2025 per ETON's latest filing, from $31.9 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $34.9 million in Q4 2024 and troughed at $463000.0 in Q3 2021.
- A 5-year average of $11.1 million and a median of $4.7 million in 2022 frame the typical range for Goodwill & Intangibles.
- The sharpest annual moves came in 2021 and 2022: Goodwill & Intangibles decreased 24.35% in 2021, then soared 974.08% in 2022.
- Over 5 years, Goodwill & Intangibles stood at $3.6 million in 2021, then surged by 31.29% to $4.8 million in 2022, then decreased by 0.32% to $4.7 million in 2023, then soared by 636.04% to $34.9 million in 2024, then fell by 11.48% to $30.9 million in 2025.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $30.9 million, $31.9 million, and $32.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Eton Pharmaceuticals | 1.67 Bn | 1.65 Bn | 25.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 54.54 Mn |
| Dec 31, 2025 | 30.88 Mn |
| Sep 30, 2025 | 31.88 Mn |
| Jun 30, 2025 | 32.88 Mn |
| Mar 31, 2025 | 33.88 Mn |
| Dec 31, 2024 | 34.88 Mn |
| Sep 30, 2024 | 5.85 Mn |
| Jun 30, 2024 | 6.12 Mn |
| Mar 31, 2024 | 6.39 Mn |
| Dec 31, 2023 | 4.74 Mn |
| Sep 30, 2023 | 4.21 Mn |
| Jun 30, 2023 | 4.39 Mn |
| Mar 31, 2023 | 4.57 Mn |
| Dec 31, 2022 | 4.75 Mn |
| Sep 30, 2022 | 4.97 Mn |
| Jun 30, 2022 | 3.11 Mn |
| Mar 31, 2022 | 4.24 Mn |
| Dec 31, 2021 | 3.62 Mn |
| Sep 30, 2021 | 463,000.00 |
| Jun 30, 2021 | 500,000.00 |